Venetoclax Combined with “7+3” Induction Chemotherapy Induces High MRD-Negative Response Rates in Newly Diagnosed AML Patients Fit for Intensive Chemotherapy across Ages
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Ioannis Mantzaris, Matan Uriel, Mendel Goldfinger, Aditi Shastri, Nishi Shah, Kira Gritsman, Noah Kornblum, Lauren Shapiro, R. Alejandro Sica, Annemarie Munoz, Nicole Chambers, Aradhika Dhawan, Karen Fehn, Balda Tirone, Lamisha Shah, Shaunmonique Clark, Mimi Kim, Chenxin Zhang, Dennis L Cooper, Amit Verma, Marina Konopleva, Eric J. Feldman
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405044388